US
Umang Shah
Charotar University of Science and Technology Ramanbhai Patel College of Pharmacy, Veer Narmad South Gujarat University, NALSAR University of Law, The M.S.University of Baroda
0000-0001-6748-2137
About
Umang Shah
M.Pharm(Pharmaceutical Chemistry)
PG Diploma In Patent Law(PGDPL)
Teaching: 10 years and 05 Months (Date of Joining 1st July 2008)
Research: 09 years
Industry: 02 Years
PG students guided: 12
Publication:26
Book:03
Employment
-
Charotar University of Science and Technology Ramanbhai Patel College of Pharmacy Assistant Professor2011 - Present
-
Veer Narmad South Gujarat University Lecturer2009 - 2011
Education
-
NALSAR University of Law P G Diploma in Patent Law2012 - 2013
-
The M.S.University of Baroda M.Pharm., Pharmaceutical Chemistry2007 - 2009
-
Hemchandracharya North Gujarat University B.Pharm2001 - 2005
Projects & Funding
Projects & funding information is unavailable.
Publications (117)
- Molecular modelling and structure-activity relationship of pyrrolo[2,3- d ]pyrimidine derivatives as potent DNA gyrase B inhibitors Save
- Design, Synthesis, and Evaluation of Nitroimidazole N-arylacetamides as Anti-TB Agents Save
- Anticancer potential of 1,2,3-triazole-tethered isonicotinate hybrids: Synthesis, in-silico studies, in-vitro studies and MD simulation Save
- Molecular Docking, Dynamics, and Cytotoxicity Assessment of Pyrazolo[1,5‐a]pyrimidine Derivatives Against Breast Cancer Save
- Enhanced Tumor Treatment Outcomes of PEGylated Liposomal Gefitinib in Non-Small Cell Lung Cancer: A Comprehensive Preclinical Evaluation with Superior Therapeutic Efficacy Save
- Harnessing the Power of Ferulic Acid: A Comprehensive Review of its Therapeutic Mechanisms, Delivery Innovations, and Clinical Impact Save
- Green Synthesis of Pyrazole Linked Thiazole Derivatives With Enhanced Anti‐Breast Cancer Activity: Water Extract of Banana Peel‐Mediated Protocol, Anticancer Screening, Epidermal Growth Factor Receptor Inhibition, In Silico Absorption–Distribution–Metabo… Save
- Pharmaceutical Industry Manufacturing Trend for Tablet Dosage Forms and Opportunities for the Future; A Case Study of Current Practice and Future Developments Save
- A New Green and Efficient Method for Pyranopyrazoles Synthesis in a Single Pot Using Multiple Components, In Silico Pharmacokinetics with Cytotoxic Assessments Save
- Asciminib - ABL Kinase Inhibitor in the Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia: Chemistry and Pharmacology Perspectives Save